(Q34215746)

31 July 2017

1 reference

title

Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U). (English)

1 reference

31 July 2017

Bouma BN

1

1 reference

31 July 2017

Marx PF

series ordinal

2

1 reference

31 July 2017

Mosnier LO

series ordinal

3

1 reference

31 July 2017

Meijers JC

series ordinal

4

1 reference

31 July 2017

1 March 2001

1 reference

31 July 2017

1 reference

31 July 2017

101

1 reference

31 July 2017

5

1 reference

31 July 2017

329-354

1 reference

Three-dimensional structure of porcine procarboxypeptidase B: a structural basis of its inactivity

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Mapping the pro-region of carboxypeptidase B by protein engineering. Cloning, overexpression, and mutagenesis of the porcine proenzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Analysis of the activation process of porcine procarboxypeptidase B and determination of the sequence of its activation segment.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Crystal structure of the complex of carboxypeptidase A with a strongly bound phosphonate in a new crystalline form: comparison with structures of other complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

An enzyme in human blood plasma that inactivates bradykinin and kallidins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Basic carboxypeptidases: regulators of peptide hormone activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Human carboxypeptidase N: lysine carboxypeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Familial carboxypeptidase N deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Purification and characterization of a new arginine carboxypeptidase in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Protein C and fibrinolysis: a link between coagulation and fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Activated human plasma carboxypeptidase B is retained in the blood by binding to alpha2-macroglobulin and pregnancy zone protein

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Activation and characterization of procarboxypeptidase B from human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Activation of thrombin-activable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Proteolytic activation of purified human procarboxypeptidase U

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

A carboxypeptidase inhibitor from the medical leech Hirudo medicinalis. Isolation, sequence analysis, cDNA cloning, recombinant expression, and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Molecular cloning and partial characterization of rat procarboxypeptidase R and carboxypeptidase N

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

The gene encoding human plasma carboxypeptidase B (CPB2) resides on chromosome 13

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

The gene for human carboxypeptidase U (CPU)--a proposed novel regulator of plasminogen activation--maps to 13q14.11.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Plasma carboxypeptidases as regulators of the plasminogen system

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

C-terminal lysine residues of fibrinogen fragments essential for binding to plasminogen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Superficial accumulation of plasminogen during plasma clot lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasmi

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Factor XI deficiency in Ashkenazi Jews in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Factor XI activation in a revised model of blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Solution structure of the smallest cofactor-active fragment of thrombomodulin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

The inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieu: effect of thrombomodulin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Plasma lipoproteins enhance tissue factor-independent factor VII activation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

An antifibrinolytic mechanism describing the prothrombotic effect associated with factor VLeiden

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

1 reference

7 January 2021

Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

High levels of coagulation factor XI as a risk factor for venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Refolding of potato carboxypeptidase inhibitor by molecular dynamics simulations with disulfide bond constraints a aEdited by A. R. Fersht

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Expression of a synthetic gene encoding potato carboxypeptidase inhibitor using a bacterial secretion vector

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Contribution of C-tail residues of potato carboxypeptidase inhibitor to the binding to carboxypeptidase A A mutagenesis analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Inhibition of radiation-induced transformation of C3H/10T1/2 cells by carboxypeptidase inhibitor 1 and inhibitor II from potatoes.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Potato carboxypeptidase inhibitor, a T-knot protein, is an epidermal growth factor antagonist that inhibits tumor cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Protein C activation on endothelial cells by prothrombin activation products generated in situ: meizothrombin is a better protein C activator than alpha-thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Inducible carboxypeptidase activity. A role in clot lysis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Cellular carboxypeptidases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Purification and characterization of human metallocarboxypeptidase Z.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Cloning and expression of human carboxypeptidase Z, a novel metallocarboxypeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

A eukaryotic transcriptional repressor with carboxypeptidase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

Enzymic characterization of a novel member of the regulatory B-like carboxypeptidase with transcriptional repression function: stimulation of enzymic activity by its target DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900411-4

7 January 2021

10.1016/S0049-3848(00)00411-4

Identifiers

DOI

1 reference

release_h3h5swl655fsrfmm3t2hvlalke

31 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h3h5swl655fsrfmm3t2hvlalke

24 November 2022

mapped directly with Wikidata item

1 reference